US judge upholds law to curb hospital drug prices as shortage trends show mixed signals
A federal judge in Washington rejected a pharmaceutical industry challenge to a state law aimed at lowering hospital drug prices, leaving the pricing reforms in place.
Data from a recent analysis show that the number of prescription‑drug shortages in the United States fell by 23% last year, marking the second year of decline and the lowest level since 2017.
However, the same analysis highlighted a troubling increase in the average duration of shortages, projecting an average of 5.3 years in 2025 compared with 4.3 years in 2024.
The column also notes growing U.S. pressure on European drug pricing, adding another layer of complexity for manufacturers navigating global markets.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more”
read at STAT ↗
comments(0)
5-min edit window · permanent after that